BLLN
BillionToOne, Inc. Class A Common StockNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$3.32B
P/E Ratio
554.77
EPS
$0.13
Beta
—
52W High
$138.70
52W Low
$61.96
50-Day MA
$77.13
200-Day MA
$87.94
Dividend Yield
—
Profit Margin
0.96%
Forward P/E
—
PEG Ratio
—
About BillionToOne, Inc. Class A Common Stock
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company is headquartered in Menlo Park, California.
Fundamentals
| Revenue (TTM) | $305.11M |
| Gross Profit (TTM) | $208.46M |
| EBITDA | $22.93M |
| Operating Margin | 10.80% |
| Return on Equity | 2.30% |
| Return on Assets | 2.14% |
| Revenue/Share (TTM) | $19.22 |
| Book Value | $10.48 |
| Price-to-Book | 7.40 |
| Price-to-Sales (TTM) | 10.87 |
| EV/Revenue | 10.38 |
| EV/EBITDA | 160.26 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 113.10% |
| Shares Outstanding | $41.44M |
| Float | $23.16M |
| % Insiders | 46.74% |
| % Institutions | 36.03% |
Historical Volatility
HV 10-Day
58.36%
HV 20-Day
74.64%
HV 30-Day
84.72%
HV 60-Day
84.77%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($116.71 target)
2
Strong Buy4
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 5/5/2026